Amanda M. Laird, MD,FACS

I am an endocrine surgeon, Chief of the Section of Endocrine Surgery at Rutgers Cancer Institute of New Jersey as well as an Associate Professor of Surgery at Rutgers Robert Wood Johnson Medical School. I treat endocrine tumors of the thyroid, parathyroid glands, and adrenal glands. These tumors are uniquely different as they may secrete hormones in excess and may occur as a part of a familial genetic syndrome. I also treat neuroendocrine tumors which have similar characteristics and may occur anywhere throughout the body. What I love most about the field of endocrine surgery is that there is not a “one size fits all” approach to the care of my patients – an individualized treatment plan is developed for each patient and their tumor type. My expertise is in both traditional open surgical techniques as well as minimally invasive surgery techniques. Working closely with a multidisciplinary team that includes surgical oncologists, endocrinologists, medical oncologists, nuclear medicine radiologists, radiation oncologists, nurses, and genetic counselors, I provide coordinated care for my patients that results in improved outcomes. I track my patients’ outcomes as part of my clinical research that helps guide advancements in treatment options. Prior to joining Rutgers Cancer Institute, I was an Assistant Professor of Surgery at Montefiore Medical Center and Albert Einstein College of Medicine where I was Director of Endocrine Surgery. I serve on several committees for both the American Association of Endocrine Surgeons and the Association of Academic Surgery. My clinical research has yielded peer-reviewed publications, reviews, book chapters, and both national and international presentations. After graduation from Louisiana State University and Louisiana State University Health Sciences Center in Shreveport, Louisiana, I completed my residency in general surgery at Wake Forest University in Winston-Salem, North Carolina. I then completed the Norman Thompson Fellowship in Endocrine Surgery at the University of Michigan. Clinical Expertise Endocrine tumors, neuroendocrine tumors, carcinoid tumors, thyroid surgery, parathyroid surgery, adrenal gland surgery, adrenocortical cancer, pheochromocytoma, paraganglioma, multiple endocrine neoplasia, minimally invasive surgery, and clinical trials.

Publications:

A. Refereed Original Article in Journal 1. Insurance type is associated with appropriate use of surgical and adjuvant care for differentiated thyroid carcinoma. Theismeyer JW, Limberg J, Ullmann TM, Greenberg JA, Egan CE, Moore M, Finnerty BM, Laird AM, Zarnegar R, Fahey TJ 3rd, Beninato T. Surgery, 2021. 2. Association of the Affordable Care Act with access to highest-volume centers for patients with thyroid cancer. Greenberg JA, Thiesmeyer JW, Ullmann TM, Egan CE, Valle Reyes F, Moore MD, Ivanov NA, Laird AM, Finnerty BM, Zarnegar R, Fahey TJ 3rd, Beninato T. Surgery, 2021. 3. Impact of the COVID-19 pandemic on the practice of endocrine surgery. Beninato T, Laird AM, Graves CE, Drake FT, Alhefdhi A, Lee JA, Kuo JH, Grubbs EG, Wang TS, Pasieka JL, Lubitz CC. American Journal of Surgery, 2021 4. Radiology report language positively influences adrenal incidentaloma guideline adherence. Watari J, Vekaria S, Lin Y, Patel M, Kim H, Kang F, Lubitz S, Beninato T, Laird AM. American Journal of Surgery, 202 5. Assessing the immediate impact of COVID-19 on surgical oncology practice: Experience from an NCI-designated Comprehensive Cancer Center in the Northeastern United States. Gazivoda V, Greenbaum A, Rashal J, Lee J, Reddy L, Rehman S, Kangas-Dick A, Gregory S, Kowzun M, Stephenson R, Laird A, Alexander HR, Berger AC. Journal of Surgical Oncology, 2021 6. Outcomes of Adrenalectomy and the Aldosteronoma Resolution Score in the Black and Hispanic Population. Romero-Velez, G, Laird AM, Barajas ME, Sierra-Salazar M, Herrera M, Libutti SK, Parides MK, Pereira X, McAuliffe JC. World Journal of Surgery, 2021 7. Yeung A, Friedmann P, In H, Bloomgarden H, Mcauliffe JC, Libutti SK, Laird AM. Evaluation of Adrenal Vein Sampling Use and Outcomes in Primary Aldosteronism. Journal of Surgical Research, 2020 8. Bresler A, Mehta V, Schiff B, Smith R, Khader S, Rivera G, Lin J, Libutti SK, Laird AM, Ow TJ. Comparison of Bethesda Cytopathology Classification to Surgical Pathology Across Racial-Ethnic Groups. Head and Neck, 41(7) 2340-2345, 2019 9. Rosenberg A; Friedmann, P; Del Rivero, J; Libutti, SK; Laird, AM. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors. Surgery, 159(1) 302-9, 2016 10. Siddiqi, HK; Yang, HY; Laird, AM; Fox, AC; Doherty, GM; Miller, BS; Gauger, PG. Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas. Surgery, 152(6), 1027-36, 2012 11. Hughes, DT; Laird, AM; Miller, BS; Gauger, PG; Doherty, GM. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Annals of Surgical Oncology. 19(9), 2951-7, 2012 12. Laird AM; Gauger PG; Miller, BS; Doherty, GM. Evaluation of postoperative radioactive iodine scans in patients undergoing prophylactic central lymph node dissection. World Journal of Surgery. 36(6), 1268-73, 2012 13. Laird, AM; Gauger, PG; Doherty, GM; Miller, BS. Paraganglioma: Not just an extra-adrenal pheochromocytoma. Langenbeck’s Archives of Surgery. 397(2), 247-53, 2012 14. Laird, AM; Miller, PR; Chang, MC; Kilgo, P; Meredith, JW. The effects of early hyperglycemia on mortality in trauma patients. Journal of Trauma. 56(5), 1058-62, 2004. B. Books, Monographs and Chapters 1. Laird, Amanda M; Libutti, Steven K; The multiple endocrine neoplasia syndromes; In: Townsend’s Sabiston Textbook of Surgery, 21st edition; edited by Courtney Townsend with Daniel Beauchamp, Mark Evers and Kenneth Mattox, in press 2. Laird, Amanda M; Libutti, Steven K; In: Diagnosis and management of nonfunctional pancreatic neuroendocrine tumors. Treatment and Management of Endocrinopathies, 1st Edition; edited by Alexander Shifrin; Elsevier, Philadelphia, PA, 2019 3. Laird, Amanda M; Steward, David; Doherty, Gerard M. “Central Neck Dissection: Indications”; In: Surgery of the Thyroid and Parathyroids, 2nd Edition; edited by Gregory Randolph; p367-72; Elsevier, Philadelphia, PA, 2013 A. Other Articles (Reviews, Editorials, etc.) In Journals; Chapters; Books; other Professional Communications 1. Total Thyroidectomy and Low-Risk Thyroid Cancer: Are We Treating the Surgeon or the Patient? Laird AM, Beninato T. Annals of Surgical Oncology, 2021 2. Is Less More? Adoption of Treatment Guidelines for Low-Risk Papillary Thyroid Cancer. Beninato T, Laird AM. Annals of Surgical Oncology, 2021 3. From Diagnosis to Therapy—PET Imaging for Pheochromocytomas and Paragangliomas. Patel HV, Srivastava A, Becker MD, Beninato T, Laird AM, Singer ES. Current Urology Reports, 2021 4. Beninato T, Laird AM. Shedding new light on old complications: CESQIP and understanding post-thyroidectomy outcomes. American Journal of Surgery, May 2020 5. Laird, AM; Libutti, SK; The Management of Gastroenteropancreatic Neuroendocrine Tumors. Surgical Oncology Clinics of North America. In press. 6. Laird, AM; Libutti, SK; Mimimally invasive parathyroidectomy versus bilateral neck exploration for primary hyperparathyroidism. Surgical Oncology Clinics of North America. Vol 25, p103-118, 2016. 7. Wong, KK, Laird AM, Moubayed A, Chondrogiannis S, Marzola MC, Evangelista L, Gross MD, Rubello D. How has the surgical management of medullary thyroid carcinoma changed with the advent of FDG and non-FDG PET radiopharmaceuticals. Nuclear Medicine Communications. Vol 33, p679-688, 2012